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doi:10.1016/j.jtcvs.2003.11.019674 The Journal of Thoracic and CardioObjectives: To compare durability of tricuspid valve annuloplasty techniques,
identify risk factors for repair failure, and characterize survival, reoperation, and
functional class of surviving patients.
Methods: From 1990 to 1999, 790 patients (mean age 65  12 years, 51% New
York Heart Association functional class III or IV, and mean right ventricular
systolic pressure 56  18 mm Hg) underwent tricuspid valve annuloplasty for
functional regurgitation using 4 techniques: Carpentier-Edwards semi-rigid ring,
Cosgrove-Edwards flexible band, De Vega procedure, and customized semicircular
Peri-Guard annuloplasty. Of these patients, 89% had concomitant mitral valve
surgery. A total of 2245 follow-up transthoracic echocardiograms were retrieved.
Tricuspid regurgitation was analyzed, and risk factors for worsening regurgitation
were identified, by multivariable ordinal longitudinal methods.
Results: Tricuspid regurgitation 1 week after annuloplasty was 3 or 4 in 14% of
patients. Regurgitation severity was stable across time with the Carpentier-Edwards
ring (P .7), increased slowly with the Cosgrove-Edwards band (P .05), and rose
more rapidly with the De Vega (P  .002) and Peri-Guard (P  .0009) procedures.
Risk factors for worsening regurgitation included higher preoperative regurgitation
grade, poor left ventricular function, permanent pacemaker, and repair type other
than ring annuloplasty. Right ventricular systolic pressure, ring size, preoperative
New York Heart Association functional class, and concomitant surgery were not
risk factors. Tricuspid reoperation was rare (3% at 8 years), and hospital mortality
after reoperation was 37%.
Conclusions: Tricuspid valve annuloplasty did not consistently eliminate functional
regurgitation, and across time regurgitation increased importantly after Peri-Guard
and De Vega annuloplasties. Therefore, these repair techniques should be aban-
doned, and transtricuspid pacing leads should be replaced with epicardial leads.
Surgery for tricuspid valve disease has been relatively ignored. Be-tween 1991 and 2000, 1498 papers were published in English aboutmitral valve surgery and 1447 about aortic valve surgery, but only 335about tricuspid valve surgery.1 The Carpentier ring, designed specif-ically for tricuspid valve repair, was released over 30 years ago,2 yetmost tricuspid valve repairs are still either suture-based or done with
rings originally released for mitral valve repair.3-7
Most series of tricuspid valve repairs are small and focus on gross outcomes such
as freedom from reoperation or survival. However, freedom from reoperation may
seriously underestimate the prevalence of residual or recurrent tricuspid regurgita-
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risk” and may not be offered,8 and late survival depends on
many factors other than durability of tricuspid valve repair.
With increasing prevalence of heart failure and surgical
intervention for severe left ventricular dysfunction, sur-
geons now encounter tricuspid regurgitation regularly.9,10
Therefore, we examined our experience with repair of func-
tional tricuspid regurgitation to (1) determine durability of
annuloplasty techniques, (2) identify risk factors for repair
failure (including type of annuloplasty), and (3) characterize
reoperation, survival, and functional class of surviving pa-
tients.
Patients and Methods
Patients
From January 1990 to January 1999, 790 patients underwent
annuloplasty for functional tricuspid valve regurgitation at The
Cleveland Clinic Foundation. Patients with endocarditis, rheu-
matic valve disease, or organic disease of the tricuspid valve
leaflets, including congenital anomalies, were excluded.
Patients were identified and preoperative, operative, and post-
operative variables retrieved from the prospective computerized
Cleveland Clinic Cardiovascular Information Registry. This data-
base has been approved for research by the institutional review
board (IRB).
Four types of annuloplasty were employed: classic Carpentier-
Edwards semi-rigid ring, Cosgrove-Edwards flexible band, De
Vega procedure, and a customized semicircular annuloplasty using
bovine pericardium (Peri-Guard). All were used during the entire
study period except for the Cosgrove-Edwards band, which be-
came available in 1995 (Table 1). Annuloplasty type used de-
pended on device availability and surgeon preference. Sizing of the
tricuspid valve was at the discretion of the surgeon. One patient
was excluded from follow-up analysis because annuloplasty type
could not be determined.
Mean age of patients was 65 years (range 18-88), and 64%
were women. Preoperative tricuspid regurgitation was 4 in 44%
of patients, 3 in 43%, and 0 or 1 in 2.9%. Right ventricular
systolic pressure was similar at baseline in each of the 4 groups.
Left ventricular ejection fraction (EF) was highest in the group
undergoing Peri-Guard annuloplasty and lowest in the group un-
dergoing the De Vega procedure. Tricuspid valve repair was the
sole procedure in only 36 patients (5%). Concomitant procedures
included mitral valve operation in 89% and aortic valve operation
TABLE 1. Distribution of tricuspid annuloplasty techniques
Technique
1990 1991 1992 1993
No. % No. % No. % No. %
Carpentier 32 55 8 13 15 21 15 26
Cosgrove 0 0 0 0 0 0 1 2
De Vega 13 22 8 13 6 8 2 3
Peri-Guard 13 22 45 74 50 71 40 69in 27% (Table 2).
The Journal of ThoraciFollow-up
Patients were followed routinely every 2 years after operation, then
cross-sectionally in 2000. Data were obtained for 725 patients
(92%) by telephone interview with them, their families, or physi-
cians using an IRB-approved questionnaire. Echocardiographic
reports were solicited, as well as functional status, vital status, and
occurrence of tricuspid valve reoperations. Patients untraced cross-
sectionally were considered traced from operation to time of last
contact for reoperations, functional status, and echocardiography;
the Social Security Death Index was used to determine vital status.
A total of 3302 patient-years of follow-up information was avail-
able for analysis.
Assessment of Repair
Preoperative and postoperative transthoracic echocardiographic
reports were utilized to assess tricuspid regurgitation grade and
right ventricular systolic pressure. Echocardiograms were per-
formed routinely before discharge and at the discretion of referring
physicians during follow-up. None of the echocardiographic data
in this report is based on intraoperative studies. Interpretation of
follow-up echocardiograms was obtained at as many time points as
available for each patient.
A total of 2245 postoperative echocardiogram reports were
retrieved; 65 patients had none available for analysis. Median time
of echocardiographic assessment was 6 months (25th percentile 
1 week, 75th percentile  3 years, range 0-11.8 years). Tricuspid
regurgitation was graded as 0 for no regurgitation, 1 for mild
regurgitation, 2 for moderate regurgitation, 3 for moderately
severe regurgitation, and 4 for severe regurgitation.
Data Analysis
The following questions were addressed:
1. What is the durability of tricuspid valve repair?
2. Did durability differ among the 4 annuloplasty techniques?
3. What are the risk factors for repair failure?
4. How many patients had reoperation for tricuspid valve dis-
ease?
5. What was the New York Heart Association (NYHA) func-
tional class at follow-up?
6. Did right ventricular systolic pressure change over time?
7. What is survival following tricuspid valve repair?
8. Do patients with high residual tricuspid regurgitation have a
longer postoperative hospital stay?
To address the first 3 questions, postoperative and follow-up
transthoracic echocardiograms were analyzed for change in tricus-
r the study period
1994 1995 1996 1997 1998
No. % No. % No. % No. % No. %
9 13 10 13 9 10 18 13 23 14
0 0 16 21 47 55 88 64 137 83
5 7 16 20 28 33 32 22 6 3
57 80 36 46 2 2 0 0 0 0ovepid regurgitation across time. Temporal patterns of change among
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each. Risk factors for time-related increase in grade of tricuspid
regurgitation were identified. Freedom from tricuspid valve reop-
eration was assessed by time-related analyses.
NYHA class was assessed by temporal frequencies, right ven-
tricular systolic pressure by longitudinal data analysis, survival by
time-related analyses, and impact of tricuspid regurgitation on
length of stay by a series of indirect analyses. Analytic methods for
TABLE 2. Patient characteristics overall and by annulopla
Overall
No. % No
Number 789 100 13
Age (years  SD) 65  12
Female gender 505 64 8
NYHA
III 293 37 4
IV 110 14 2
Tricuspid regurgitation grade
0 5 0.6
1 18 2.3
2 70 9
3 340 43 4
4 348 44 8
Unavailable 8 1
Mitral regurgitation grade
3 141 18 2
4 334 42 4
Aortic regurgitation grade
3 41 5 1
4 36 4.5
Left ventricular dysfunction
None 312 40 5
Mild 110 14 2
Moderate 91 12 2
Severe 47 6
Unavailable 229 29 3
LV ejection fraction (mm Hg  SD) 45  9
RV systolic pressure (mm Hg  SD) 56  18
Permanent pacemaker 75 9.5 1
Previous cardiac surgery 401 51
Concomitant procedures*
None 36 5
Mitral valve replacement 425 54 9
Mitral valve repair 276 35 2
Coronary artery bypass 205 26 2
Aortic valve replacement 199 25 4
Aortic valve repair 15 2
Tricuspid ring size (mm)
26
28 1
30 3
32 4
34 2
36
SD, Standard deviation; NYHA, New York Heart Association; LV, left ventr
*Procedures not mutually exclusive.these data are presented in Appendix 1.
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Longitudinal ordinal logistic regression for repeated measurements
(SAS PROC GENMOD) was used to analyze change in postop-
erative regurgitation over time,11 both overall and separately for
each annuloplasty technique.
Because the temporal trend of tricuspid regurgitation showed
steep changes in the first 6 months following annuloplasty, risk
factors for higher grades of regurgitation were sought separately
echnique*
ntier Cosgrove De Vega Peri-Guard
% No. % No. % No. %
17 291 37 116 15 243 31
11 66  11 62  13 64  13
63 181 62 69 59 167 69
35 118 41 38 33 88 36
14 42 14 29 25 19 8
0 2 0.6 2 2 1 0.4
1 7 2.4 7 6 2 0.8
5 31 11 18 16 14 6
36 136 47 50 43 106 44
59 112 38 35 30 119 49
0 3 1 4 3 1 0.4
16 43 15 26 22 50 21
30 145 50 50 43 97 40
7 18 6 3 2.5 10 4
5 14 5 9 8 6 2
39 113 39 29 25 116 48
18 36 12 11 9 38 16
14 23 8 21 18 27 11
3 20 7 15 13 8 3
25 99 34 40 34 54 22
8 45  10 40  11 46  7
20 54  18 55  15 57  19
10 41 14 11 9 9 4
5 17 6 6 5 6 3
65 149 51 41 35 145 60
19 102 35 64 55 83 34
21 87 30 44 38 45 19
32 81 28 28 24 46 19
0.7 7 2 2 2 5 2
3 65 22
13 107 37
27 69 24
34 43 15
17 5 1.5
6 2 0.5
; RV, right ventricular.sty t
Carpe
.
9
64 
8
9
0
0
2
7
8
2
0
2
2
0
7
4
5
0
4
6
44 
58 
4
7
0
7
9
4
1
4
8
7
7
4
9
icularfor (1) the first 6 months (early) and (2) after 6 months (see
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of a particular annuloplasty type, a balancing score technique
utilizing propensity matching was employed (described in Appen-
dix 1).12,13
Focused Studies
The influence of temporal change in tricuspid regurgitation was
investigated with respect to presence of preoperative permanent
pacemaker, preoperative left ventricular function, and preoperative
transthoracic echocardiographic tricuspid regurgitation grade. For
the latter, preoperative regurgitation grades 0, 1, and 2 were
grouped because of their rarity.
Reoperation
Freedom from tricuspid valve reoperation was estimated both
nonparametrically14 and parametrically,15 and the hazard function
was estimated (see http://www.clevelandclinic.org/heartcenter/
hazard).
Results
Tricuspid annuloplasty utilizing a Cosgrove-Edwards flex-
ible band was the most frequently performed technique. The
most commonly used sizes were 28 mm and 30 mm, com-
pared with 30 mm and 32 mm for the classic Carpentier-
Edwards ring (see Table 2).
Durability
Change in tricuspid regurgitation across time. Overall,
the proportion of patients with regurgitation grade 0 de-
creased rapidly within the first 6 months, followed by a
more gradual decline, and the proportion with 3 or 4
regurgitation rose sharply initially, then continued rising
more gradually (Table 3). One month postoperatively, prev-
alence of 3 or 4 regurgitation was 15% for the Carpen-
tier-Edwards ring, 15% for the Cosgrove-Edwards band,
14% for the De Vega procedure, and 15% for Peri-Guard
TABLE 3. Predicted prevalence across time of grades 3
techniques*
Technique TR grade
1 month
% CL (%)
Carpentier 3 10 9-11 1
4 5.2 4.6-5.9
Cosgrove 3 10 9-11 1
4 5.3 4.6-6.0
De Vega 3 9 8-10 1
4 4.6 4-5
Peri-Guard 3 10 9-11 1
4 5.4 4.8-6.0
Overall 3 10 9-11 1
4 5 5-6
TR, Tricuspid regurgitation; CL, 68% confidence limits; N/A, not applicable
*Model-based time-related estimates (%).annuloplasty (see Table 3).
The Journal of ThoraciRegurgitation grade evolved differently among the 4
repair techniques (Figure 1). Severity of regurgitation was
stable across time with the Carpentier-Edwards ring (P 
.7) and increased slowly with the Cosgrove-Edwards band
(P  .05); however, in comparison with one another, the
temporal pattern was similar (P .6) (Figure 2). Severity of
regurgitation rose more rapidly with both the De Vega
procedure (P  .002; P  .06 compared with the Carpen-
tier-Edwards ring) and Peri-Guard annuloplasty (P .0009;
P  .002 compared with the Carpentier-Edwards ring) (see
Figure 2).
Size of the Carpentier-Edwards ring or Cosgrove-Ed-
wards band did not influence evolution of regurgitation over
time (P  .6).
Risk factors. Higher preoperative transthoracic echocar-
diographic tricuspid regurgitation was a risk factor for re-
turn of higher grades of tricuspid regurgitation within 6
months (Table 4). Risk factors beyond 6 months included
greater left ventricular dysfunction, presence of permanent
pacemaker, and Peri-Guard annuloplasty.
Prevalence of 3 or 4 regurgitation among patients
with a preoperative permanent pacemaker increased from
16% at 1 month postoperatively to 42% at 5 years, com-
pared with 15% and 23%, respectively, for those without a
pacemaker (Figure 3).
Prevalence of 3 or 4 regurgitation among patients in
preoperative left ventricular functional classes 1 (EF 
50%), 2 (EF 36%-49%), 3 (EF 25%-35%), and 4 (EF 
25%) increased from 14%, 15%, 17%, and 20% at 1 month
postoperatively to 26%, 15%, 31%, and 28% at 5 years,
respectively (Figure 4).
In patients with preoperative tricuspid regurgitation
grades 0 versus 1 and 2 versus 3 and 4, prevalence
of 3 or 4 tricuspid regurgitation increased from 9%,
4 tricuspid valve regurgitation for various annuloplasty
1 year 5 years 8 years
CL (%) % CL (%) % CL (%)
9-12 11 9-13 11 8-14
4.7-6.3 6 4.3-7.4 6 4-8
11-13 12 9-14 N/A
6-7 6 5-8 N/A
10-13 17 15-20 20 17-22
5-7 11 9-13 13 10-16
12-14 19 17-21 22 19-24
6-8 13 10-15 15 12-18
11-14 15 14-17 19 17-21
6-8 9 8-10 12 10-15
enough patients in follow-up at this time).and
%
0
5.5
2
6
2
6
3
7
3
7
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29% at 5 years, respectively (Figure 5).
There was no evidence of interaction between permanent
pacemaker and left ventricular dysfunction (P  .4), per-
manent pacemaker and preoperative tricuspid regurgitation
(P  .4), or left ventricular dysfunction and preoperative
tricuspid regurgitation (P  .6). Each factor had an inde-
pendent effect.
Right ventricular systolic pressure, ring size, preopera-
tive NYHA functional class, or need for concomitant sur-
gery were not identified as risk factors.
Reoperation
Freedom from reoperation was 99% at 1 month postopera-
tively and 97% at 8 years. Risk of reoperation was 4.2% per
year at 30 days, fell to 0.08% per year by 3 years, and
increased to 2.9% per year by 10 years. Thirty-day operative
Figure 1. Tricuspid regurgitation (TR) grade change o
predicted mean percent of patients in each regurgita
grouped data for TR grade. Open squares  0; open ci
 4. A, Cosgrove-Edwards flexible band. B, Peri-Gu
Vega procedure.mortality after reoperation (n  6) was 32%, and 1 other
678 The Journal of Thoracic and Cardiovascular Surgery ● Marpatient died later in-hospital, making hospital mortality
37%. Survival at 1 year and 3 years was 31% and 19%,
respectively.
Functional Status
Of the patients who were 4 years or more postoperative,
24% were in NYHA functional class III or IV (Table 5).
Right Ventricular Systolic Pressure
Postoperative mean right ventricular systolic pressure in-
creased from 42 mm Hg at postoperative day 1 to 45 mm Hg
at 8 years (P  .02) and was not influenced by annuloplasty
type (P  .12).
Survival
Thirty-day operative mortality for the 790 patients was 6%,
and hospital mortality was 8%. Survival was 65% at 5 years
ime for each annuloplasty technique. Curves indicate
grade from longitudinal modeling. Symbols represent
 1; solid circles  2; triangles  3; diamonds
annuloplasty. C, Carpentier-Edwards rigid ring. D, Dever t
tion
rcles
ardand 50% at 8 years.
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Principal Findings
This study has important implications for the cardiac sur-
gery and cardiology communities. We found that residual
and recurrent regurgitation after tricuspid annuloplasty was
common and some of its risk factors correctable. However,
reoperation for tricuspid regurgitation was rare, despite the
return of many patients to NYHA class III or IV. The low
rate of reoperation may be due in part to the perception that
this is a high-risk procedure, which was verified in this
study.
Residual tricuspid regurgitation occurred in 14% of pa-
tients early after operation for all types of annuloplasty. This
prevalence is much higher than after mitral valve repair,
even for functional ischemic mitral regurgitation.16-18 By 6
months, Peri-Guard annuloplasty was already showing
more recurrent regurgitation than the Carpentier-Edwards
ring. The higher the grade of preoperative tricuspid regur-
gitation, the higher the risk of repair failure within 6
months. However, most indicators of early worsening were
markers of patient disease and as such could not be altered
by the surgeon.
Late worsening (beyond 6 months) of tricuspid regurgi-
tation was associated not only with patient disease factors
but also with avoidable causes such as transtricuspid pacing
leads and type of annuloplasty. Results with the Carpentier-
Edwards ring showed little change in tricuspid regurgitation
over time, and the Cosgrove-Edwards band showed mini-
mal increase. In contrast, the 2 nonring annuloplasties, De
Vega and Peri-Guard, showed substantial worsening in late
tricuspid regurgitation. Theoretically, persistent pulmonary
hypertension may have affected the nonring repairs and
allowed the annulus to gradually redilate because right
ventricular systolic pressure did not importantly decrease
during late follow-up. Other studies also have shown late
recurrence of tricuspid regurgitation following De Vega
repair, including a randomized trial versus the Carpentier-
Edwards ring.19 Other suture-based methods of tricuspid
valve repair are also inferior to the Carpentier-Edwards
ring.20 Therefore, 1 risk factor for late tricuspid regurgita-
tion could be eliminated by avoiding De Vega and Peri-
Guard annuloplasties.
Second, we identified permanent pacemakers as a risk
factor for late, but not early, regurgitation. Right ventricular
pacing leads that traverse the tricuspid valve may cause
regurgitation by several mechanisms: (1) they may be an-
chored in such a way that they are fixed in the right ventricle
and inhibit leaflet motion, (2) they may perforate a leaflet or
pin the leaflet to ventricular muscle, or (3) scar tissue or
thrombus may form around them, impairing leaflet mobility.
Another important risk factor for late failure was left
ventricular dysfunction. Success of biventricular synchro-
nous pacing for patients with severe left ventricular dys-
The Journal of Thoracifunction and left bundle branch block, along with results of
the MADIT II trial, suggest that there will be many patients
with the combination of severe left ventricular dysfunction
and electrical leads that traverse the tricuspid valve.21,22
This will be especially important because moderate or se-
vere tricuspid regurgitation occurs in 35% of patients with
left ventricular EFs below 35%, and survival is poor.9,23
Therefore, we investigated whether these factors are multi-
plicative and put patients at even higher risk of tricuspid
valve repair failure; this did not turn out to be the case. Five
years after valve repair, 42% of patients with a permanent
pacemaker had severe regurgitation, almost twice as high as
those without the device. This suggests that removing the
transtricuspid lead and replacing it with an epicardial lead
may reduce late repair failure.
Some variables that we thought might predispose the
patient to recurrent repair failure did not prove to be statis-
tically significant after accounting for variables already in
the model. Currently, it is popular to treat functional mitral
regurgitation with an undersized valve ring to improve
leaflet coaptation.24 We thought this might apply to func-
tional tricuspid regurgitation as well and expected to find
that patients with larger tricuspid rings would be more prone
to recurrent regurgitation; this was not observed. Therefore,
the strategy of undersizing the tricuspid annulus for func-
tional tricuspid regurgitation using small rings cannot be
validated as protection against late tricuspid regurgitation.
Figure 2. Tricuspid regurgitation grades 3 and 4 postopera-
tively for each annuloplasty technique. Curves indicate predicted
mean percent of patients with 3 or 4 tricuspid regurgitation
for each annuloplasty technique. Symbols represent grouped data
according to percent of observations of 3 and 4 tricuspid
regurgitation for each annuloplasty technique. Open circles 
Carpentier-Edwards; squares  Cosgrove-Edwards; triangles 
De Vega; solid circles  Peri-Guard. TR, Tricuspid regurgitation;
RR, Carpentier-Edwards rigid ring; FB, Cosgrove-Edwards flexible
band; DV, De Vega procedure; PG, Peri-Guard annuloplasty.We also expected that right ventricular systolic pressure
c and Cardiovascular Surgery ● Volume 127, Number 3 679
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it did not.
Despite frequent recurrent 3 or 4 tricuspid regurgi-
tation, reoperation was rare (3% at 8 years). Some patients
tolerate moderate amounts of regurgitation with minimal
symptoms, and a few tolerate severe regurgitation with mild
symptoms. However, this did not appear to explain the low
occurrence of reoperation, because 24% of patients had
returned to NYHA class III or IV in late follow-up. We
cannot determine accurately whether limited functional
class was related to right heart failure symptoms and recur-
TABLE 4. Risk factors for return of higher tricuspid regurg
Risk factor
Early worsening TR grade (0-6 months)
Higher preop TTE TR
Higher BUN*
Lower pre-op MR†
Previous cardiac surgery
Lower hematocrit‡
Absence of carotid disease
Repair technique
Cosgrove vs CE
Peri-Guard vs CE
De Vega vs CE
Balancing scores
P (Cosgrove)§
P (Peri-Guard)
P (De Vega)¶
Late worsening TR grade (more than 6 months)
Female gender
Greater LV dysfunction
Presence of at least one-system disease
Presence of atrial fibrillation
Presence of permanent pacemaker
Absence of COPD
Higher creatinine#
Repair technique
Cosgrove vs CE
Peri-Guard vs CE
De Vega vs CE
Balancing scores
P (Cosgrove)**
P (Peri-Guard)††
P (De Vega)‡‡
TR, Tricuspid regurgitation; TTE, transthoracic echocardiography; BUN, b
LV, left ventricular; COPD, chronic obstructive pulmonary disease; SE, sta
*[20/BUN], inverse transformation.
†Log [MR  1], logarithmic transformation.
‡[Hematocrit/30]2, squared transformation.
§Probability for patient receiving Cosgrove ring.
Log [Probability for patient receiving Peri-Guard annuloplasty], logarithm
¶Log [Probability for patient receiving De Vega procedure], logarithmic tr
#[Creatinine]2, squared transformation.
**Log [Probability for patient receiving Cosgrove ring], logarithmic transfo
††[1/Probability for patient receiving Peri-Guard annuloplasty], inverse tra
‡‡Log [Probability for patient receiving De Vega procedure], logarithmic trent tricuspid regurgitation.
680 The Journal of Thoracic and Cardiovascular Surgery ● MarReoperation for tricuspid valve disease proved to be a
high-risk procedure, as others have found8; observed in-
hospital mortality of 37% makes this one of the highest-risk
cardiac valve operations. This poor track record may create
a self-fulfilling prophecy: patients with recurrent severe
tricuspid regurgitation are managed aggressively with di-
uretics and medication and are referred to surgery only
when they develop severe disabling symptoms including
hepatic and renal dysfunction. When the patient dies or fails
to thrive, this perpetuates the notion that tricuspid repair is
high risk. The major discrepancy between echocardio-
on grade
Coefficient  SE P
0.48 0.097 .0001
0.53 0.17 .002
0.30 0.17 .07
0.30 0.16 .05
0.32 0.18 .07
0.59 0.20 .002
0.20 0.24 .4
0.46 0.23 .05
0.068 0.27 .8
0.76 0.49 .1
0.24 0.10 .02
0.02 0.037 .6
0.81 0.19 .0001
0.63 0.17 .0002
0.54 0.20 .007
0.47 0.18 .01
0.65 0.31 .04
0.47 0.23 .04
0.032 0.007 .0001
0.40 0.32 .2
0.93 0.30 .002
0.66 0.35 .06
0.09 0.10 .3
0.0002 0.0002 .2
0.028 0.05 .6
rea nitrogen; MR, mitral regurgitation; CE, Carpentier-Edwards rigid ring;
error.
sformation.
mation.
on.
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rmation.itati
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cates an important shortcoming in any article reporting the
“success” of tricuspid valve annuloplasty techniques.
Limitations
No consistent, accurate data were available regarding right
ventricular function, right ventricular size and geometry,
tricuspid annular size, or pulmonary artery pressure; all may
be important factors influencing durability of tricuspid valve
repair. Also, this study did not attempt to analyze residual
mitral valve disease (either stenosis or regurgitation) and
correlate it with the results of tricuspid valve repair. Fur-
thermore, we were not able analytically to relate recurrent
tricuspid regurgitation to subsequent survival or progression
of NYHA class. It is unknown whether recurrent tricuspid
regurgitation led to subsequent worsening of heart failure
symptoms in patients in late follow-up or whether patients
developed heart failure from progressive left ventricular
dysfunction, with secondary pulmonary hypertension and
right ventricular dysfunction that then led to tricuspid re-
gurgitation. Finally, as with all studies of clinical experi-
ence, the data are subject to selection and ascertainment
bias. For instance, symptomatic patients might have been
more likely to receive follow-up echocardiography than
asymptomatic ones. Additionally, in longitudinal studies the
competing risk of death changes the makeup of the residual
study population; to the extent that outcomes are correlated
with death, temporal bias is introduced by this so-called
informative censoring mechanism.
Conclusion
Recurrent or residual tricuspid regurgitation after tricuspid
Figure 3. Influence of preoperative permanent pacemaker on
evolution of postoperative 3 and 4 tricuspid regurgitation.
Format is as in Figure 2. Open circles  pacemaker; solid circles
 no pacemaker. PPM, Permanent pacemaker; TR, tricuspid
regurgitation.valve annuloplasty was common, and reports defining suc-
The Journal of Thoracicess as freedom from reoperation should be suspect. Peri-
Guard and De Vega tricuspid valve annuloplasty techniques
should be abandoned. Transtricuspid pacing leads should be
removed and replaced with epicardial leads at surgery.
When other risk factors related to patient disease are
present, consideration of tricuspid valve replacement might
Figure 4. Influence of preoperative left ventricular function on
evolution of postoperative 3 and 4 tricuspid regurgitation.
Curves indicate predicted percent of patients with 3 and 4
regurgitation postoperatively in each of the 4 left ventricular
functional groups. Solid circles  preoperative left ventricular
functional grade 1; open circles  grade 2; squares  grade 3;
triangles  grade 4. TR, Tricuspid regurgitation.
Figure 5. Influence of preoperative tricuspid regurgitation grade
on evolution of postoperative 3 and 4 tricuspid regurgitation.
Curves indicate predicted percent of patients with 3 and 4
regurgitation postoperatively for patients stratified according to
preoperative regurgitation grade. Grades 0, 1, and 2 are
collapsed into 1 group. Solid circles preoperative regurgitation
grades 0, 1, and 2; open circles grade 3; squares grade
4. TR, Tricuspid regurgitation.be warranted.
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Appendix 1: Details of Data Analysis
Durability
Risk factors for failure. Because of the limited ability of SAS
PROC GENMOD for variable selection, we initially screened
variables for multivariable analysis using ordinary multivariable
logistic regression and the assumption of independence of obser-
vations with liberal entry (P  .2) and retention (P  .12) criteria
to identify candidates for repeated measurements analysis. These
candidates and their transformations of scale were entered simul-
taneously into the longitudinal model, then eliminated manually
one by one until all variables remaining had a P value of .1 or less.
Construction of propensity scores. Using Carpentier-Edwards
annuloplasty as the reference and PROC LOGISTIC (SAS) with a
generalized logit link, 3 simultaneous multivariable logistic regres-
sion equations were solved. Using known preoperative variables
(Appendix 2), factors associated with annuloplasty technique were
determined. Continuous and ordinal variables were initially ana-
lyzed by decile analysis, selecting those transformations of scale
that best calibrated the variable to the technique. Having estab-
lished a parsimonious model, other variables were added repre-
senting groups of patient and disease factors that might be related
to unrecorded selection factors (saturated model).
A propensity score for each technique was calculated for each
patient by solving the 3 simultaneous multivariable logistic regres-
sion equations. To compare techniques, these 3 scores and their
transformations of scale (where appropriate), repair type, and
interactions with repair type were forced into the multivariable
analyses.13
New York Heart Association Functional Class
NYHA functional status was available for 647 patients. Patients
were grouped by interval from operation to follow-up and percent-
tion functional class at time of follow-up
Percent of patients
NYHA II NYHA III NYHA IV
25 22 38
20 18 20
30 13 5
20 15 7
24 17 7ocia
A Iage in each NYHA functional class determined.
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Right ventricular systolic pressures were derived whenever possi-
ble from transthoracic echocardiograms, and temporal pattern of
change was analyzed. Longitudinal linear mixed-model regression
was used to analyze continuous repeated measurements of right
ventricular systolic pressure change over time (PROC MIXED).11
A total of 1268 measurements were available on 556 patients.
Median time of assessment was 7 months (25th percentile  10
days, 75th percentile 3.2 years, range 0-11.8 years). Influence of
the 4 annuloplasty techniques was determined using propensity
score–adjusted univariable models with a different repair tech-
nique as the reference group.
Survival
Nonparametric and parametric survival estimates and hazard func-
tion were obtained as described in the preceding text. Among
survivors, median follow-up was 4.5 years, with 25% followed for
3.2 years or less and 25% followed for 6.7 to 11.8 years.
Length of Hospital Stay
To investigate whether postoperative length of hospital stay was
affected by predischarge grade of tricuspid regurgitation, patients
were stratified into those with maximum in-hospital regurgitation
grade 1 or less and those with maximum grade 2 or more. Of
587 patients with postoperative echocardiograms prior to dis-
charge, 369 (63%) had tricuspid regurgitation grades 1 and
218 (37%) had2. Both groups had the maximum postoperative
in-hospital regurgitation grade recorded at a similar time interval
(P  .3). Multivariable hazard analysis and propensity score
methods (adjusted multivariable analysis and pairwise matching)
using preoperative variables alone or together with postoperative
event were used to investigate the relation between hospital stay
and regurgitation grade. Postoperative events used in the model
were stroke, bleeding, renal failure, respiratory insufficiency, sep-
ticemia, and use of intra-aortic balloon pump.
Median length of postoperative hospital stay was 9 days (25th
percentile  7 days, 75th percentile  14 days) for patients with
maximum tricuspid regurgitation grades 1 and 11 days (25th
percentile  7 days, 75th percentile  20 days) for patients with
tricuspid regurgitation grades 2 (P  .0003). Taking into
consideration preoperative variables and postoperative events, the
significance of this difference was variable, ranging from .0003 to
.1, depending on what other variables were included in the model
and whether patients were propensity matched.
Appendix 2: Variables Used in Analyses
Preoperative
Demography: Gender, age, weight, height, body surface area, body
mass index
Symptoms: New York Heart Association functional class, Cana-
dian Heart Classification
Ventricular function: Ejection fraction, left and right ventricular
function, right ventricular systolic pressures
Pathology: Mitral regurgitation, tricuspid regurgitation
Cardiac comorbidity: History of myocardial infarction, electrocar-
diographic evidence of myocardial infarction, atrial fibrillation,
complete heart block, ventricular arrhythmia, history of cardiac
The Journal of Thoracisurgery, emergency cardiac surgery, number of cardiac surger-
ies, coronary artery disease by coronary artery territory (left
main trunk, left anterior descending artery, left circumflex ar-
tery, right coronary artery)
Noncardiac comorbidity: Insulin-dependent diabetes, non–insulin-
dependent diabetes, treated diabetes, hypertension, history of
peripheral vascular disease, presence of carotid disease, pres-
ence of chronic obstructive pulmonary disease, renal disease,
history of smoking, creatinine, blood urea nitrogen, bilirubin,
hematocrit
Experience: Date of surgery
Intraoperative
Procedure: Internal thoracic artery grafts used, concomitant pro-
cedures (mitral valve repair, mitral valve replacement, aortic
valve repair, aortic valve replacement, coronary artery bypass),
annuloplasty ring, annuloplasty ring size
Support: Ischemic time, perfusion time
Discussion
Dr Steven F. Bolling (Ann Arbor, Mich). I would like to thank the
authors for allowing me to review this very elaborately analyzed
work. The authors found that in this long-term follow-up of tri-
cuspid repairs, a ring repair appeared to be more robust in terms of
good, long-term results, whereas a stitch repair or a pericardial
repair was less so.
I have a number of questions for the authors. Were they
surprised by the fact that tricuspid size at the time of operation did
not relate to recurrence of tricuspid regurgitation, and is there any
way for the authors to tell whether their type of operation was
tailored to the amount of tricuspid regurgitation seen at the oper-
ation (i.e., did those patients who had less regurgitation get a stitch
repair, those patients who were felt to have higher regurgitation get
a ring repair)?
Second, the authors did not correlate recurrence of tricuspid
regurgitation to residual mitral regurgitation. Could it be that
patients who had recurrent tricuspid regurgitation were reflective
of residual or recurrent mitral regurgitation?
Third, were they surprised by the very low reoperation rate
despite the very high recurrence of tricuspid regurgitation, and
what do the authors now tolerate at the time of operation in terms
of residual tricuspid regurgitation? In this study it appears that
14% of the patients left the hospital with significant tricuspid
regurgitation.
And last, do the authors now recommend that the rings we use
in the tricuspid annulus should be more rigid, as these appeared to
have a longer robust outcome?
Dr McCarthy. I would like to thank Dr Bolling for his ques-
tions. First, did the size of the tricuspid valve annulus seem to have
an effect on the repair durability? We did not feel that we had
adequate data from our echo studies to comment specifically about
the size of the tricuspid valve annulus. We were somewhat sur-
prised to find that the smaller rings were no better than the larger
ones at preventing late tricuspid regurgitation, but this may be
accounted for by the effects of including Barlow’s patients, who
received larger rings and fared quite well. The patients with
cardiomyopathy have smaller leaflets and may not do as well,
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Another question had to do with tailoring the type of tricuspid
annuloplasty versus the amount of tricuspid regurgitation; for
example, would we do a De Vega annuloplasty because the tri-
cuspid regurgitation was only 2 or 3? That did not appear to be
the practice according to our analysis. Much of the choice was
related to the surgeon’s preference for the type of annuloplasty
technique.
Also, we were unable to correlate late tricuspid regurgitation
with late mitral regurgitation due to statistical techniques that Dr
Blackstone tells me do not yet exist. What do we tolerate in terms
of residual tricuspid regurgitation? It should be noted that the study
looked at only transthoracic preoperative and then, later, postop-
erative studies. We are all well aware of downgrading of tricuspid
regurgitation in the operating room. I expect that none of the
patients would have left the operating room with anything greater
than 2 tricuspid regurgitation. Today if we saw a patient with
anything over 1 tricuspid regurgitation in the operating room, we
would consider that a cause for concern. If a patient has residual 3
or 4 tricuspid regurgitation on the predischarge echo, we would
seriously consider reoperating on that patient based on the analysis
of this study.
Another question had to do with the rigid ring versus the
flexible band. By multivariable analysis there was no difference in
the long-term outcome between the 2, although by univariable
analysis the flexible band did show some decrease in effectiveness.
So there was some increase in tricuspid regurgitation in that group.
Dr Alain F. Carpentier (Paris, France). I rise to congratulate
this presentation, and it confirms what Dr Deloche more than 15
years ago showed when comparing remodeling annuloplasty and
nonremodeling annuloplasty, that is to say, other techniques using
bands or sutures. He showed a 0.6% per patient-year freedom from
reoperation with remodeling versus 1.6% with the other tech-
niques, which confirmed pretty much what Dr McCarthy and his
colleagues have shown.
Now, I would like to make a kind remark, which is the use of
the term of “rigid” Carpentier ring. The tricuspid ring originally
has not been made rigid but semi-rigid so as to adapt to the
3-dimensional configuration of the tricuspid annulus when lowered
into position. So I think it would be appropriate to use the term
“semi-rigid” and to keep in mind, again, that knowing that all
tricuspid orifices have a different configuration, it is better to use
a semi-rigid rather than a strongly rigid structure to keep the
3-dimensional configuration.
Dr McCarthy. Thank you, Professor Carpentier. I would like
to agree that it is a semi-rigid ring, which is why you can bend that
ring. We referred to it as “rigid” in contrast to the other 3 types of
annuloplasty techniques.
Dr Norberto G. De Vega (Malaga, Spain). Just a few com-
ments. As I said this morning, I think that to mix rheumatic heart
disease with other diseases is not right. Most of the patients need
a tricuspid repair. Now there are many rheumatic patients, espe-
cially in the developing countries. I have been in India, in China,
and there are thousands of patients, and they need that.
And to give the message that everybody who needs a tricuspid
repair needs to have a ring implanted, to me, it is not right. Many
years ago I said the same thing about mitral repair. I think that you
684 The Journal of Thoracic and Cardiovascular Surgery ● Marcan do mitral repair without a ring. And if you have to do mitral
repair with a ring, I called that years ago “the taxed mitral repair”:
you have to pay a tax and put a ring in every case. I feel really that
most of the patients, if they need a tricuspid repair, and this is our
experience, they can have a “tax-free” tricuspid repair.
Dr McCarthy. Thank you very much. I agree that suture repair
is a very inexpensive technique, and one has to take into account
the cost of the rings. On the other hand, reoperations greatly
underestimate the number of patients who redevelop severe tricus-
pid regurgitation. In the long-term one also has to take into account
the cost of recurrent heart failure and the cost of rehospitalizations.
Over the long term rings may be more cost-effective.
Dr Kevin D. Accola (Orlando, Fla). I enjoyed your work. Dr
McCarthy, if you would elucidate a little more on what you just
mentioned regarding reoperations. On one of your conclusion
slides, you consider the possibility of tricuspid valve replacement.
With your event-free survival results being so favorable, at which
point would you put a patient through a reoperation, or even
consider a tricuspid valve replacement? That seems a little extreme
with such good results, and at that point, which valve would you
utilize?
Dr McCarthy. First of all, I think that the reoperation rate was
low for several reasons: first is that 51% of our patients were
reoperations, and so now a reoperation for the tricuspid valve
disease would be at least their third operation. Another issue is that
we don’t see these patients until many years later. The cardiolo-
gists frequently follow these patients and give diuretics. They are
trying to manage them medically, and they usually only refer them
to us when those patients are very advanced with hepatic dysfunc-
tion and sometimes other organ failure. That is why the risk of the
reoperation was so high, at 37%, because we are seeing them so
late in the natural history. For most patients we replace the valve
with a tissue valve.
Dr Rainald Seitelberger (Vienna, Austria). I also congratulate
you on this very nice study. I am referring to the patients with the
pacemaker leads, because you reported that they have a signifi-
cantly higher incidence of recurrence of insufficiency, and I would
like to ask you what surgical steps you took in those patients. I just
recently had 3 patients who had pacemaker leads: 2 of them
actually punctured the posterior leaflet of the tricuspid valve and 1
was totally adherent to the posterior leaflet of the tricuspid valve.
In all 3 cases I did a bicuspidalization of the valve together with a
ring.
My question is, do you have any specific surgical techniques to
avoid this problem?
Dr McCarthy. We have seen failures even in patients who had
the permanent pacemaker wire free of the leaflet itself because the
pacing wire may flatten the leaflet. After the analysis of this data
the safest technique may be to simply remove the wire and replace
it with a steroid-eluting epicardial pacing wire that maintains low
thresholds for many years. If at some point the epicardial pacing
wires wear out, then the patient could undergo transvenous pacing
wire placement.
Dr Gilles D. Dreyfus (London, United Kingdom). First of all, I
want to congratulate Patrick McCarthy and his group for this very
impressive series. You had said that when you now encounter regur-
gitation that would be greater than 2 you would consider going back
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that you would probably replace the valve in the inferences.
Would you consider doing a technique similar to what we do for
mitral valve in the tricuspid valve, that is, for instance, use substitute
chordal such as polytetrafluoroethylene or pericardial to extend the
anterior leaflet, or even suture the posterior to the septal commissure
and transform the tricuspid valve into a bicuspid valve in case you
have a tethering effect? Did you analyze those 14% of cases, as you
said, that were not related to the type of the technique? Therefore, you
still have some cases where the tethering effect pulls down the free
edge, and then whatever you do, even downsize, will leave a tricuspid
regurgitation. What would you do in such an instance?
Dr McCarthy. We don’t want to give the message that weThe Journal of Thoraciment. This would be in only very selected patients. For instance, in
patients with Barlow’s disease it is very rare that one would ever
consider replacing the valve. I think that those almost uniformly
could be repaired.
On the other hand, in the increasing population of patients
with cardiomyopathy, in which the leaflets themselves are nor-
mal, the right ventricle is dilated, and the leaflets are tethered,
it appears that not many of the repair techniques accomplish a
very durable repair. Then it may be safer to replace in that
group than to accept recurrent or residual tricuspid regurgita-
tion. But, again, that would be an uncommon decision. The
techniques of bicuspidization, leaflet extension with pericar-
dium, or chorded extension in this population may be worth-have a low threshold for recommending tricuspid valve replace- while, but we do not yet have that data.c and Cardiovascular Surgery ● Volume 127, Number 3 685
